HB 3177

This bill expands access to the West Virginia Controlled Substances Monitoring Database. It adds several new categories of individuals – including medical examiners, hospital physician reviewers, advanced practice nurses, hospital chief medical officers, and medical school deans – who can access prescriber-level data. The bill also creates an advisory committee to identify abnormal prescribing patterns and a review committee to investigate potential drug diversion cases, with specific guidelines for their operations and reporting. Finally, it establishes a process for sharing data with relevant licensing boards and the Department of Health while protecting patient privacy.